The SEMA Show is the premier automotive specialty products trade event in the world, drawing the industry’s brightest minds and hottest products to one place, the Las Vegas Convention Center. Additionally, SEMA provides attendees with educational seminars, product demonstrations, special events, networking opportunities and more. Mitchell will once again be attending SEMA as an exhibitor with an interactive exhibit booth, which can be found in the North Hall. Those visiting Mitchell’s booth will have the opportunity to be one of the first to demo the latest Mitchell solutions for the repair industry. We look forward to seeing you on the show floor! Need to schedule a meeting with a sales representative? Contact us today.
More stories
FDA Authorizes Second Coronavirus (SARS-CoV2) Vaccine for Use
The vaccine produced by Moderna has been granted emergency use authorization for distribution in the United States.
Mitchell Predicts 2021 Trends in Its Fourth Quarter 2020 Industry Trends Report
According to Mitchell experts, 2021 will see growth in personal vehicle ownership and electric vehicles, rising accident severity and increasing automation and digitization in the claims process.
GM and Mitchell Launch GM Collision Repair Network in Canada
New program focuses on increasing brand loyalty and customer confidence by promoting the proper, safe repair of Chevrolet, Buick, GMC and Cadillac vehicles.
Episode 1: Re-Imagining What's Possible in a Pandemic
Ryan and Tony Cotto, director of auto and underwriting policy at National Association of Mutual Insurance Companies (NAMIC), discuss the impact of COVID-19 on automotive insurers. Learn how carriers have quickly adapted to a new normal and how they’re re-imagining the future of claims post-pandemic.
FDA Authorizes Use of First at Home COVID-19 Test Kit
The test takes about 30 minutes and an indicator light will note a positive or negative result.
Bamlanivimab Granted Emergency Use Authorization For Early COVID-19 Treatment
Bamlanivimab is an investigational monoclonal antibody treatment that has shown promise in treating mild-to-moderate COVID-19 infections.